BRCA2 and breast carcinoma: - Women with a pathogenic mutation of the BRCA2 gene or othergenes who are at moderate or high risk for breast cancer, as well as those whohave not been tested but have first-degree relatives who are carriers, shouldundergo annual MRI after the diagnosis of the mutation but not before theage of 30 (category A).